RE: NONMEM and identification of drug-drug interactions

From: Ekaterina Gibiansky Date: December 19, 1997 technical Source: cognigencorp.com
From: "Gibiansky, Ekaterina" <Katyag@mocr.oapi.com> Subject: RE: NONMEM and identification of drug-drug interactions Date: 19 Dec 1997 10:07:34 -0500 Mats, I had approximately the same arguments as you do. Counter arguments were that since not all beta blockers or NSAIDs were used concomitantly in the trials we can not claim no interaction with the whole class. As soon as it comes to listing all those that were used (with only few of each) the whole idea loses any sense. Happy Holidays Katya
Dec 16, 1997 Gary Maier NONMEM and identification of drug-drug interactions
Dec 17, 1997 Janet Wade Drug Interactions
Dec 17, 1997 Mats Karlsson Re: NONMEM and identification of drug-drug interactions
Dec 17, 1997 Rene Bruno NONMEM and drug-drug interaction
Dec 17, 1997 Ziad Hussein Re: NONMEM and identification of drug-drug interactions
Dec 17, 1997 Ekaterina Gibiansky RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Mats Karlsson RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Ziad Hussein RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Cornelia Weber Re: Drug Interactions
Dec 19, 1997 Mats Karlsson Re: Drug Interactions
Dec 19, 1997 Ekaterina Gibiansky RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Robert Shore Re: Drug Interactions
Dec 19, 1997 Jeff Wald Re: Drug Interactions